New York State Common Retirement Fund Reneo Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$1.51 - $1.9 $783 - $986	-519 Reduced 81.48%	118 $0
Q1 2024 May 07, 2024	BUY	$1.59 - $1.74 $661 - $723	416 Added 188.24%	637 $1,000
Q4 2023 Feb 01, 2024	SELL	$1.34 - $8.43 $21 - $134	-16 Reduced 6.75%	221 $0
Q3 2023 Nov 07, 2023	SELL	$5.44 - $8.13 $73,238 - $109,454	-13,463 Reduced 98.27%	237 $2,000
Q2 2023 Aug 07, 2023	BUY	$5.44 - $10.5 $74,528 - $143,850	13,700 New	13,700 $90,000
Q2 2022 Aug 04, 2022	SELL	$1.96 - $3.04 $8,122 - $12,597	-4,144 Reduced 98.43%	66 $0
Q3 2021 Nov 02, 2021	SELL	$6.28 - $11.07 $55,075 - $97,083	-8,770 Reduced 67.57%	4,210 $31,000
Q2 2021 Aug 02, 2021	BUY	$7.78 - $15.0 $100,984 - $194,700	12,980 New	12,980 $121,000

31M

50.8K

Ticker RPHM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,479,600
Market Cap $41.1M
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.